LCAT and chronic kidney disease: The activity of LCAT was similar in all of the analyzed stages of chronic kidney disease (Table 1), and there were no significant correlations between LCAT activity and preβ1-HDL (R = −0.05; p = 0.968) or LpA-I concentration (R = 0.233; p = 0.062).